Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces it

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis

Cardiol Therapeutics Inc.: Cardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Brazil , Israel , France , Toronto , Ontario , Canada , America , David Elsley , Trevor Burns , European Union , Newsfile Corp , Nasdaq , Drug Administration , Cardiol Therapeutics Inc , Company Phase , Company Annual Report On Form , Cardiol Therapeutic President , Chief Executive , Pilot Phase , North America , Investigational New Drug Application , United States Food , Cardiol Therapeutics , Annual Report , Investor Relations ,